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Abstract The burden of respiratory disease has persisted
over the years, for both men and women. The aim of
the present study was to investigate the hospital episode
rates in respiratory disease and to understand whether
and how the use of the health service for respiratory
disease might have changed in recent years in the
North-East of England. Hospital episode data covering
two full calendar years (in 2013–2014) was extracted
from the Northumbria Healthcare NHS Foundation
Trust, which serves a population of nearly half a mil-
lion. Hospital episode rates were calculated from admis-
sions divided by annual and small area-specific popula-
tion size by sex and across age groups, presented with
per 100,000 person-years. The use of the health service
for influenza and pneumonia, acute lower respiratory
infections and chronic obstructive pulmonary disease
(COPD) increased with an advancing age, except for
acute upper respiratory infections and asthma. Overall,
the use of the health service for common respiratory
diseases has seemed to be unchanged, except for asth-
ma. There were large increases in young adults aged
20–50 for both men and women and the very old aged
90+ in women. Of note, there were large increases in
acute lower respiratory infections for both men and
women aged 90+, whereas there was also a large de-
crease in COPD in women aged 80–90. This is the first
study to examine health service use for respiratory dis-
eases by calculating the detailed population size as de-
nominator. Re-diverting funding to improve population
health on a yearly basis may serve the changing need in
local areas.
Introduction
Evidence before this study
Respiratory disease, as an adult health condition, affects mil-
lions of people globally and is the one of the leading causes of
health issues in both developed and developing countries [1].
Health service use has increased in older persons and costs
millions of pounds in the UK, USA and several European
countries, which could prompt considerations on long-term
healthcare together with the entire socio-economic structure
[2–5]. Hospital admissions have seemed to decrease in some
regions, whereas in other regions primary care consultations
seem to have increased, likely due to different study popula-
tions, study time periods and/or estimation methods in rates
[6–28]. Continuously monitoring how people consume the
health service because of various health conditions is important
in assisting with individual, local and national health profiles
and with the re-allocation of medical and social recourse effec-
tively and consequently to prevent from unnecessary pain and
spending. Therefore, such clinical evidence is necessary.
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Knowledge gap
Investigating admission rates and hospitalisation rates could
be perceived as a direct way of understanding how many
patients are admitted and hospitalised require health service
utilisation. Previous research tended to estimate age-
standardised rates using the population census in a certain year
by accommodating a specific population structure (e.g.
Europe) or by adjusting for all ages in a specific study catch-
ment to compare across countries and/or regions. However,
looking at the total age-standardised rate by using the
population census in a certain year may sometimes mis-
lead and misguide the re-allocation of local medical and
social resources, as one national, international or global
policy does not always fit all owing to different unadjust-
ed historical contexts (i.e. biological or non-biological risk
contributor profiles).
Study aim
Following this context, therefore, the aim of the present
study was to investigate the age-specific hospital epi-
sode rates in common respiratory diseases by sex and
across age groups using an annual and small area-
a) All 
b) Female 
c) Male 
Fig. 1 Population size by sex and
across age groups in Northumbria
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specific population size to understand and establish the
monitoring on whether and how the use of the health
service for respiratory diseases may have changed in
recent years, if at all.
Materials and methods
Study sample
Hospital Episode Statistics (HES; more details via http://
www.hscic.gov.uk/hes) is a data warehouse containing
details of all admissions, outpatient appointments and
A&E attendances at National Health Service (NHS) hos-
pitals in England. These data are collected during a pa-
tient's time at hospital and are submitted to allow hospi-
tals to be paid for the care they deliver. HES data are
designed to enable secondary use, particularly for non-
clinical purposes. Each NHS trust in England collects its
own patient data, and the anonymised data are kept lo-
cally within each trust and also centrally at the national
level. Northumbria Healthcare NHS Foundation Trust
(more details via https://www.northumbria.nhs.uk/)
covers the health service mostly for Northumberland
a) All
b) Female 
c) Male 
Fig. 2 Distribution of rates of
health service use for BJ00–J06:
acute upper respiratory
infections^
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and North Tyneside, including three major hospitals
(Hexham General Hospital, North Tyneside General
Hospital and Wansbeck General Hospital) and other
smaller community hospitals (Alnwick Infirmary,
Berwick Infirmary, Blyth Community Hospital ,
Hal twhis t le War Memoria l Hospi ta l , Rothbury
Community Hospital and Sir G B Hunter Memorial
Hospital) facilitating health and social care and well-
being for rehabilitation purposes (more details via
h t t p : / /www.nh s . u k / S e r v i c e s /Tr u s t s /Ove r v i ew /
DefaultView.aspx?id=1802) and acts as a foundation trust
that has been free from central government control since
2006 (more details via https://www.northumbria.nhs.uk/
about-us/being-foundation-trust).
a) All 
b) Female 
c) Male 
Fig. 3 Distribution of rates of
health service use for BJ09–J18:
influenza and pneumonia^
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Variables and analyses
The data from the Northumbrian Hospital Episodes used in
the present study covered two full calendar years (2013–
2014). Health service use was determined by each admission
coded as J00-06 Acute upper respiratory infections, J09-18
Influenza and pneumonia, J20-J22 Acute lower respiratory
infections, G44 Other chronic obstructive pulmonary disease
(COPD) and J45 Asthma, based on the International
Classification of Diseases, 10th version (more details via
http://apps.who.int/classifications/icd10/browse/2015/en;
now re-directed to http://apps.who.int/classifications/
icd10/browse/2016/en). To estimate the usage of the
health service, age-specific HES rates were calculated
from admissions divided by population size for each
age group, presented with per 100,000 person-years.
Estimates on population size in both 2013 and 2014
were obtained from the UK Office for National
a) All
b) Female 
c) Male 
Fig. 4 Distribution of rates in
health service use for BJ20–J22:
other acute lower respiratory
infections^
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Statistics (more details via http://www.ons.gov.uk/ons/
taxonomy/index.html?nscl=Population). Statistical
software STATA version 13.0 (STATA, College Station,
Texas, USA; more details via http://www.stata.com/) and
Microsoft Excel (more details via https://products.office.
com/en-us/excel) were used to perform all the analyses
and to generate graphs. As this was only a secondary
data analysis with no individual identification in the present
study, no further ethics approval was required.
Results
Figure 1 describes the population size by sex and
across age groups in mid-2013 to mid-2014. Clearly,
the population of young adults (aged 20–49) has de-
creased, whereas that of older adults (aged 50 and
above) has increased. Figures 2–6 show the distribu-
tion of rates of health service use for acute upper
respiratory infections, influenza and pneumonia, acute
a) All
b) Female 
c) Male 
Fig. 5 Distribution of rates of
health service use for BJ44:
COPD^ (chronic obstructive
pulmonary disease)
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lower respiratory infections, COPD and asthma from
2013 to 2014 by sex and age groups respectively (also
see Tables 1–5). Clearly, the use of the health service
for influenza and pneumonia, acute lower respiratory
infections and COPD increased with an advancing age
in both men and women, but not for acute upper re-
spiratory infections and asthma. Following these 2
years, the use of the health service for common
respiratory diseases has seemed to be unchanged, ex-
cept for asthma. There were large increases in young
adults aged 20–50 for both men and women and the
very old aged 90 and above in women. Of note, there
were large increases in acute lower respiratory infec-
tions for both men and women aged 90 and above;
there was also a large decrease in COPD in women
aged 80–90.
a) All 
b) Female 
c) Male 
Fig. 6 Distribution of rates of
health service use for BJ45:
asthma^
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Discussion
Methodologically, there are a number of ways of examining
hospital admissions, i.e. the use of the health service, in the
population. To be specific, we could look historically at the
trends by day of the week, by month, by season or by year. We
could also examine geographically by hospital, by city, by
region or by country. Mathematically, we could estimate by
number, by rate or by standardisation. Politically, we could
assess by practice, by policy or by reform. For example, re-
spiratory admissions declined accompanying an increase in
smoke-free areas or with the introduction of immunisation
[29–33]. Understanding the use of the health service in
the bigger picture is critical for health service providers
and policy makers to effectively re-allocate medical and
social resources (from prevention to rehabilitation) re-
spectively. The targeted at-risk population may shift fol-
lowing the change in investment in health and nursing
Table 1 Hospital episode
statistics for BJ00–J06: acute
upper respiratory infections^
2014 2013
All
(years)
Episode Population 2014 HES
rate
All age groups
(years)
Episode Population 2013 HES
rate
0–9 775 55,577 1394.461738 0–9 802 55,550 1443.744374
10–19 47 55,577 84.567357 10–19 30 56,221 53.36084381
20–29 44 54,879 80.17638805 20–29 14 55,221 25.3526738
30–39 30 58,734 51.07774032 30–39 14 58,955 23.74692562
40–49 21 72,433 28.99231013 40–49 10 74,655 13.3949501
50–59 27 77,070 35.0330868 50–59 16 75,724 21.12936453
60–69 13 70,296 18.49322863 60–69 7 69,558 10.06354409
70–79 14 45,482 30.78140803 70–79 11 44,044 24.97502498
80–89 6 23,764 25.2482747 80–89 13 23,324 55.73658035
90+ 9 4,919 182.9640171 90+ 8 4,716 169.6352841
Total 164 40,7577 40.23779556 Total 93 406,197 22.89529465
Female (years)
0–9 309 26,728 1156.090991 0–9 327 26767 1221.653529
10–19 32 26,938 118.7912985 10–19 19 27247 69.73244761
20–29 30 27,406 109.4650806 20–29 6 27663 21.68962152
30–39 17 30,170 56.34736493 30–39 11 30200 36.42384106
40–49 14 37,372 37.4612009 40–49 5 38432 13.00999167
50–59 22 39,723 55.38353095 50–59 11 38943 28.24641142
60–69 7 36,233 19.31940496 60–69 4 35817 11.16788117
70–79 8 24,226 33.02237266 70–79 7 23546 29.72904103
80–89 5 14,148 35.3406842 80–89 5 14045 35.5998576
90+ 9 3,525 255.3191489 90+ 6 3407 176.1080129
Total 112 212,803 52.63083697 Total 55 212053 25.936912
Male (years)
0–9 466 28,849 1615.30729 0–9 475 28,783 1650.279679
10–19 15 28,609 52.43105317 10–19 11 28,558 38.51810351
20–29 14 27,473 50.9591235 20–29 8 27,558 29.02968285
30–39 13 28,564 45.51183308 30–39 3 28,755 10.43296818
40–49 7 35,061 19.9652035 40–49 5 36,223 13.80338459
50–59 5 37,347 13.38795619 50–59 5 36,781 13.59397515
60–69 6 34,063 17.61442034 60–69 3 33,741 8.891259892
70–79 6 21,256 28.22732405 70–79 4 20,498 19.51409894
80–89 1 9,616 10.39933444 80–89 8 9,279 86.21618709
90+ 0 1,394 0 90+ 2 1,309 152.7883881
Total 52 194,774 26.69760851 Total 38 194,144 19.57310038
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programs and the subsequent risk contributor profile
(biologically or non-biologically). Therefore, the perfor-
mance review of such ought to be documented regular-
ly, preferably annually.
Strengths and limitations
The present study has a few strengths. First, the data
are from recent years. Therefore, the results provide
information on recent health policy use. Second, the
study period covers full calendar years. In addition,
the population size was estimated on a yearly basis.
Therefore, selection bias could be avoided in the pre-
sentation of trends and the estimation of rates could be
more accurate than using the population census from a
single year. However, mis-classification may not be
completely avoidable [34, 35]. Third, this is the first
HES study looking at the use of the health service in
Table 2 Hospital episode
statistics for BJ09–J18: influenza
and pneumonia^
2014 2013
All
(years)
Episode Population 2014 HES
rate
All age groups
(years)
Episode Population 2013 HES
rate
0–9 67 55,577 120.5534664 0–9 66 55,550 118.8118812
10–19 26 55,577 46.78194217 10–19 16 56,221 28.4591167
20–29 41 54,879 74.70981614 20–29 31 55,221 56.13806342
30–39 73 58,734 124.2891681 30–39 75 58,955 127.215673
40–49 147 72,433 202.9461709 40–49 147 74,655 196.9057665
50–59 312 77,070 404.8267808 50–59 272 75,724 359.1991971
60–69 620 70,296 881.9847502 60–69 600 69,558 862.5894937
70–79 1,069 45,482 2,350.38037 70–79 868 44,044 1,970.756516
80–89 1,494 23,764 6,286.820401 80–89 1,420 23,324 6,088.149546
90+ 625 4,919 12,705.83452 90+ 561 4,716 11,895.6743
Total 4,474 407,577 1,097.706691 Total 4,056 406, 197 998.5302698
Female (years)
0–9 28 26,728 104.7590542 0–9 27 26,767 100.8704748
10–19 10 26,938 37.12228079 10–19 9 27,247 33.03115939
20–29 25 27,406 91.22090053 20–29 24 27,663 86.75848606
30–39 46 30,170 152.4693404 30–39 29 30,200 96.02649007
40–49 76 37,372 203.3608049 40–49 80 38,432 208.1598668
50–59 156 39,723 392.7195831 50–59 141 38,943 362.0676373
60–69 300 36,233 827.9744984 60–69 300 35,817 837.591088
70–79 482 24,226 1,989.597953 70–79 398 23,546 1,690.308333
80–89 750 14,148 5,301.102629 80–89 780 14,045 5,553.577786
90+ 391 3,525 11,092.19858 90+ 333 3,407 9,773.994717
Total 2,264 212,803 1,063.894776 Total 2,121 212,053 1,000.221643
Male (years)
0–9 39 28,849 135.1866616 0–9 39 28,783 135.4966473
10–19 16 28,609 55.92645671 10–19 7 28,558 24.51152041
20–29 16 27,473 58.23899829 20–29 7 27,558 25.40097249
30–39 27 28,564 94.52457639 30–39 46 28,755 159.9721788
40–49 71 35,061 202.504207 40–49 67 36,223 184.9653535
50–59 156 37,347 417.7042333 50–59 131 36,781 356.1621489
60–69 320 34,063 939.4357514 60–69 300 33,741 889.1259892
70–79 587 21,256 2,761.573203 70–79 470 20,498 2,292.906625
80–89 744 9,616 7,737.104825 80–89 640 9,279 6,897.294967
90+ 234 1,394 16,786.22669 90+ 228 1,309 17,417.87624
Total 2,210 194,774 1,134.648362 total 1,935 194,144 996.6828746
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respiratory disease from the Northumbria area, which is
free from central governmental control. However, there
are also a few limitations that cannot be ignored. First,
it was not possible to link with population surveys to
understand patient risk contributor profiles, whether bi-
ological or non-biological. However, the entire study
focus was to investigate if and how different age groups
could present any change in health service use in recent
years. Second, only two genders were identified. In oth-
er words, transgender was not properly coded.
Therefore, no results on transgender people could be
obtained (more details via http://www.ons.gov.uk/ons/
about-ons/business-transparency/freedom-of-information/
what-can-i-request/previous-foi-requests/health-and-
social-care/transgender-population-figures/index.html).
Third, some coding errors might not be 100%
avoidable, which would affect the estimates. Taken
together, future studies retaining the strengths and
overcoming the limitations mentioned above to
continuously monitor and document such clinical
Table 3 Hospital episode
statistics for BJ20–J22: other acute
lower respiratory infections^
2014 2013
All
(years)
Episode Population 2014 HES
rate
All age groups
(years)
Episode Population 2013 HES
rate
0–9 436 55,577 784.4971841 0–9 372 55,550 669.6669667
10–19 10 55,577 17.99305468 10–19 9 56,221 16.00825314
20–29 40 54,879 72.8876255 20–29 10 55,221 18.10905272
30–39 48 58,734 81.72438451 30–39 28 58,955 47.49385124
40–49 83 72,433 114.5886543 40–49 49 74,655 65.63525551
50–59 105 77,070 136.239782 50–59 102 75,724 134.6996989
60–69 180 70,296 256.0600888 60–69 134 69,558 192.6449869
70–79 304 45,482 668.3962886 70–79 229 44,044 519.9346108
80–89 339 23,764 1,426.527521 80–89 359 23,324 1,539.187103
90+ 188 4,919 3,821.915023 90+ 138 4,716 2,926.208651
Total 1,733 407,577 425.1957299 Total 1,430 406,197 352.0459285
Female (years)
0–9 186 26,728 695.8994313 0–9 153 26,767 571.5993574
10–19 3 26,938 11.13668424 10–19 3 27,247 11.01038646
20–29 23 27,406 83.92322849 20–29 8 27,663 28.91949535
30–39 27 30,170 89.49287372 30–39 21 30,200 69.53642384
40–49 46 37,372 123.086803 40–49 22 38,432 57.24396336
50–59 63 39,723 158.5982932 50–59 50 38,943 128.3927792
60–69 65 36,233 179.3944747 60–69 46 35,817 128.4306335
70–79 129 24,226 532.4857591 70–79 114 23,546 484.1586681
80–89 190 14,148 1,342.945999 80–89 211 14,045 1,502.313991
90+ 148 3,525 4,198.58156 90+ 108 3,407 3,169.944232
Total 880 212,803 413.5280048 Total 736 212,053 347.0830406
Male (years)
0–9 250 28,849 866.581164 0–9 219 28,783 760.8657888
10–19 7 28,609 24.46782481 10–19 6 28,558 21.00987464
20–29 17 27,473 61.87893568 20–29 2 27,558 7.257420713
30–39 21 28,564 73.51911497 30–39 7 28,755 24.34359242
40–49 37 35,061 105.5303614 40–49 27 36,223 74.53827679
50–59 42 37,347 112.458832 50–59 52 36,781 141.3773416
60–69 115 34,063 337.6097232 60–69 88 33,741 260.8102902
70–79 175 21,256 823.2969514 70–79 115 20,498 561.0303444
80–89 149 9,616 1,549.500832 80–89 148 9,279 1,594.999461
90+ 40 1,394 2,869.440459 90+ 30 1,309 2,291.825821
Total 853 194,774 437.9434627 Total 694 194,144 357.4666227
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evidence from the local setting to the national setting
would be recommended.
Research, practice and policy implications
From 2013 to 2014, there has been unchanged use of health
service utilisation with regard to common respiratory diseases,
except for asthma. Respiratory disease is a common condition
that has a large and negative impact on quality of life and life
expectancy, with high financial costs. To direct future re-
search, local health policy and guidelines could benefit from
annual clinical records on health service use for respiratory
diseases. From the practice and policy perspectives, re-
organising and re-diverting funding to improve population
health on a yearly basis, including improving the role of health
and nursing professionals in reducing the burden of
Table 4 Hospital episode
statistics for BJ44: COPD^
(chronic obstructive pulmonary
disease)
2014 2013
All (years) Episode Population 2014 HES rate All Episode Population 2013 HES rate
0–9 1 55,577 1.799305468 0–9 0 55,550 0
10–19 0 55,577 0 10–19 0 56,221 0
20–29 0 54,879 0 20–29 2 55,221 3.621810543
30–39 6 58,734 10.21554806 30–39 1 58,955 1.696208973
40–49 35 72,433 48.32051689 40–49 30 74,655 40.18485031
50–59 245 77,070 317.8928247 50–59 255 75,724 336.7492473
60–69 670 70,296 953.1125526 60–69 598 69,558 859.7141953
70–79 930 45,482 2,044.764962 70–79 902 44,044 2,047.952048
80–89 656 23,764 2,760.478034 80–89 722 23,324 3,095.523924
90+ 114 4,919 2,317.544216 90+ 108 4,716 2,290.076336
Total 2,657 407,577 651.9013585 Total 2,618 406,197 644.5148536
Female (years)
0–9 0 26,728 0 0–9 0 26,767 0
10–19 0 26,938 0 10–19 0 27,247 0
20–29 0 27,406 0 20–29 0 27,663 0
30–39 4 30,170 13.25820351 30–39 2 30,200 6.622516556
40–49 20 37,372 53.51600128 40–49 21 38,432 54.64196503
50–59 136 39,723 342.3709186 50–59 127 38,943 326.1176591
60–69 342 36,233 943.8909282 60–69 304 35,817 848.7589692
70–79 521 24,226 2,150.582019 70–79 493 23,546 2,093.773889
80–89 385 14,148 2,721.232683 80–89 471 14,045 3,353.506586
90+ 60 3,525 1,702.12766 90+ 56 3,407 1,643.674787
Total 1,468 212,803 689.8398989 Total 1,474 212,053 695.1092416
Male (years)
0–9 1 28,849 3.466324656 0–9 0 28,783 0
10–19 0 28,609 0 10–19 0 28,558 0
20–29 0 27,473 0 20–29 2 27,558 7.257420713
30–39 2 28,564 7.001820473 30–39 0 28,755 0
40–49 15 35,061 42.78257893 40–49 9 36,223 24.84609226
50–59 109 37,347 291.857445 50–59 128 36,781 348.0057638
60–69 328 34,063 962.9216452 60–69 294 33,741 871.3434694
70–79 409 21,256 1924.162589 70–79 409 20,498 1,995.316616
80–89 271 9,616 2818.219634 80–89 251 9,279 2,705.03287
90+ 54 1,394 3873.74462 90+ 52 1,309 3,972.49809
Total 1,189 194,774 610.4510869 Total 1,145 194,144 589.7684193
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rehabilitation and raising public awareness, attitude and
knowledge may serve the changing need in local areas.
Compliance with ethical standards
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Table 5 Hospital episode
statistics for BJ45: asthma^ 2014 2013
All (years) Episode Population 2014 HES rate All Episode Population 2013 HES rate
0–9 99 55,577 178.1312413 0–9 100 55,550 180.0180018
10–19 58 55,577 104.3597171 10–19 48 56,221 85.3773501
20–29 99 54,879 180.3968731 20–29 35 55,221 63.3816845
30–39 91 58,734 154.9358123 30–39 60 58,955 101.7725384
40–49 105 72,433 144.9615507 40–49 83 74,655 111.1780859
50–59 88 77,070 114.1819125 50–59 70 75,724 92.44096984
60–69 70 70,296 99.57892341 60–69 73 69,558 104.9483884
70–79 59 45,482 129.7216481 70–79 56 44,044 127.1455817
80–89 47 23,764 197.7781518 80–89 47 23,324 201.5091751
90+ 26 4,919 528.562716 90+ 17 4,716 360.4749788
Total 742 407,577 182.0514897 Total 589 406,197 145.0035328
Female (years)
0–9 38 26,728 142.1730021 0–9 24 26,767 89.6626443
10–19 30 26,938 111.3668424 10–19 26 27,247 95.42334936
20–29 61 27,406 222.5789973 20–29 24 27,663 86.75848606
30–39 74 30,170 245.276765 30–39 41 30,200 135.7615894
40–49 74 37,372 198.0092048 40–49 67 38,432 174.3338884
50–59 70 39,723 176.2203258 50–59 52 38,943 133.5284904
60–69 44 36,233 121.4362598 60–69 53 35,817 147.9744256
70–79 44 24,226 181.6230496 70–79 38 23,546 161.3862227
80–89 34 14,148 240.3166525 80–89 42 14,045 299.0388038
90+ 24 3,525 680.8510638 90+ 15 3,407 440.2700323
Total 493 212,803 231.6696663 Total 382 212,053 180.1436433
Male (years)
0–9 61 28,849 211.445804 0–9 76 28,783 264.0447486
10–19 28 28,609 97.87129924 10–19 22 28,558 77.03620702
20–29 38 27,473 138.3176209 20–29 11 27,558 39.91581392
30–39 17 28,564 59.51547402 30–39 19 28,755 66.07546514
40–49 31 35,061 88.4173298 40–49 16 36,223 44.17083069
50–59 18 37,347 48.1966423 50–59 18 36,781 48.93831054
60–69 26 34,063 76.3291548 60–69 20 33,741 59.27506594
70–79 15 21,256 70.56831012 70–79 18 20,498 87.81344521
80–89 13 9,616 135.1913478 80–89 5 9,279 53.88511693
90+ 2 1,394 143.472023 90+ 2 1,309 152.7883881
Total 249 194,774 127.8404715 Total 207 194,144 106.6218889
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